Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema
CONCLUSIONS: Berotralstat 150 mg daily has been proven safe and effective in clinical studies and appears to be a viable oral alternative to parenteral medications currently used in HAE prophylaxis.PMID:34282650 | DOI:10.1177/10600280211032982
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Jason Powell Chris Piszczatoski Eric Rubido Source Type: research